The Medicines and Healthcare products Regulatory Agency (MHRA) approved formulations do not explicitly prohibit use based solely on chronological age, and no dose adjustment is required based on age alone
22 However, the fact that the magnitude and speed of hemoglobin A1c reduction with treatment were identified as risk factors for progression suggests it could be another example of the well-established early worsening phenomenon first observed in type 1 diabetic patients intensively treated with insulin in the Oslo Study, Kroc Collaborative Study and Diabetes Control and Complications Trial
Contraindications include personal or family history of medullary thyroid carcinoma and multiple endocrine neoplasia syndrome type 2
Lifestyle: 3045 min post-meal walk, resistance/yoga 34/week, 78 hours sleep, stress management through pranayama, and 2.53 L water daily
Gribble is a Wellcome Trust Senior Research Fellow in Clinical Science and F
Inject as close to the affected area as safely possible